- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02759809
OptiMoM Kindergarten Study
January 11, 2019 updated by: Deborah O'Connor, The Hospital for Sick Children
Optimizing Mothers' Milk for Preterm Infants (OptiMoM) Program of Research: Study 1-Impact of Donor Milk at Kindergarten
In Canada, the leading cause of long-term disability in children is being born at very low birth weight (VLBW).
To help improve outcomes, nutrition is a modifiable aspect of infant care.
Mother's milk is the optimal way to feed VLBW infants; however, many need a supplement of donor milk or preterm formula as not enough mother's milk is available.
As the ideal supplement for prolonged feeding and its long-term effects is currently unknown, this study is a prospective follow up of VLBW infants who in hospital were fed: donor milk or preterm formula and/or mother's milk.
Areas of development to be assessed include: cognition, language, motor skills, brain structure/function, and body composition.
A DNA biorepository will also be created.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
158
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 6 years (Child)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Very low birth weight infants previously enrolled in the DoMINO (Donor Milk for Improved Neurodevelopmental Outcomes) trial (ISRCTN35317141).
Description
Inclusion Criteria:
- Children who were enrolled in the DoMINO (Donor Milk for Improved Neurodevelopmental Outcomes) trial (ISRCTN35317141).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Children previously assigned to donor milk in the DoMINO trial
This study is an observational study of children who were enrolled in a previous trial (DoMINO trial) between 2010 and 2012 during which they were randomized to receive donor milk when mother's own breastmilk was unavailable.
Donor milk was from a milk bank part of the Human Milk Banking Association of North America (HMBANA).
|
|
Children previously assigned to formula in the DoMINO trial
This study is an observational study of children who were enrolled in a previous trial (DoMINO trial) between 2010 and 2012 during which they were randomized to receive preterm formula when mother's own breastmilk was unavailable.
Preterm formula was either Similac Special Care or Enfamil Premature depending on hospital contract with formula companies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Full-Scale IQ on the Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV)
Time Frame: 5.5 years of age
|
5.5 years of age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Verbal IQ on the WPPSI-IV
Time Frame: 5.5 years of age
|
5.5 years of age
|
|
Performance IQ on the WPPSI-IV
Time Frame: 5.5 years of age
|
5.5 years of age
|
|
General Language Composite on the WPPSI-IV
Time Frame: 5.5 years of age
|
5.5 years of age
|
|
Processing Speed Quotient on the WPPSI-IV
Time Frame: 5.5 years of age
|
5.5 years of age
|
|
Growth
Time Frame: 5.5 years of age
|
Growth as assessed using weight, height and waist circumference measurements.
|
5.5 years of age
|
Body Composition
Time Frame: 5.5 years of age
|
Body composition as assessed using the COSMED BOD POD and skinfold thickness.
|
5.5 years of age
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Affect Recognition domain on the NEPSY-II
Time Frame: 5.5 years of age
|
5.5 years of age
|
|
Language domain on the NEPSY-II
Time Frame: 5.5 years of age
|
5.5 years of age
|
|
Memory domain on the NEPSY-II
Time Frame: 5.5 years of age
|
5.5 years of age
|
|
Visual-Motor Integration using the Beery
Time Frame: 5.5 years of age
|
5.5 years of age
|
|
Development of Brain Structure
Time Frame: 5.5 years of age
|
Development of brain structure as assessed using Magnetic Resonance Imaging (MRI).
|
5.5 years of age
|
Development of Brain Function
Time Frame: 5.5 years of age
|
Development of brain function as assessed using Magnetoencephalography (MEG).
|
5.5 years of age
|
Interaction of genetic differences and feeding type on outcomes
Time Frame: 5.5 years of age
|
Assessed using a buccal cell biorepository.
|
5.5 years of age
|
Influence of the diet on epigenetic changes
Time Frame: 5.5 years of age
|
Assessed using a buccal cell biorepository.
|
5.5 years of age
|
School Readiness using the Early Development Instrument (EDI)
Time Frame: 5.5 years of age
|
5.5 years of age
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Xu J, Shin J, McGee M, Unger S, Bando N, Sato J, Vandewouw M, Patel Y, Branson HM, Paus T, Pausova Z, O'Connor DL. Intake of mother's milk by very-low-birth-weight infants and variation in DNA methylation of genes involved in neurodevelopment at 5.5 years of age. Am J Clin Nutr. 2022 Oct 6;116(4):1038-1048. doi: 10.1093/ajcn/nqac221.
- Walton K, McGee M, Sato J, Law N, Hopperton KE, Bando N, Kiss A, Unger SL, O'Connor DL. Social-emotional functioning and dietary intake among children born with a very low birth weight. Appl Physiol Nutr Metab. 2022 Jul 1;47(7):737-748. doi: 10.1139/apnm-2021-0434. Epub 2022 Feb 23.
- McGee M, Unger S, Hamilton J, Birken CS, Pausova Z, Kiss A, Bando N, O'Connor DL. Associations between Diet Quality and Body Composition in Young Children Born with Very Low Body Weight. J Nutr. 2020 Nov 19;150(11):2961-2968. doi: 10.1093/jn/nxaa281.
- McGee M, Unger S, Hamilton J, Birken CS, Pausova Z, Kiss A, Bando N, O'Connor DL. Adiposity and Fat-Free Mass of Children Born with Very Low Birth Weight Do Not Differ in Children Fed Supplemental Donor Milk Compared with Those Fed Preterm Formula. J Nutr. 2020 Feb 1;150(2):331-339. doi: 10.1093/jn/nxz234.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
July 1, 2018
Study Completion (Actual)
July 1, 2018
Study Registration Dates
First Submitted
April 26, 2016
First Submitted That Met QC Criteria
April 28, 2016
First Posted (Estimate)
May 3, 2016
Study Record Updates
Last Update Posted (Actual)
January 14, 2019
Last Update Submitted That Met QC Criteria
January 11, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000053053
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Very Low Birth Weight
-
The Hospital for Sick ChildrenRecruitingVery Low Birth Weight InfantCanada
-
Princess Amalia Children's ClinicCompleted
-
Baylor College of MedicineRecruitingInfant, Very Low Birth WeightUnited States
-
Wyss Institute at Harvard UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
The Hospital for Sick ChildrenUniversity of Toronto; Sinai Health SystemCompletedInfant, Very Low Birth WeightCanada
-
Children's Hospital of Fudan UniversityCompleted
-
Children's Hospital of Fudan UniversityCompleted
-
Children's Hospital of Fudan UniversityNot yet recruitingVery Low Birth Weight InfantChina
-
Baylor College of MedicineCompletedInfant, Very Low Birth WeightUnited States
-
Norwegian University of Science and TechnologyCompletedInfant, Very Low Birth WeightNorway
Clinical Trials on Pasteurized donor human breastmilk
-
National Center for Research Resources (NCRR)Baylor College of MedicineCompletedSepsis | Necrotizing EnterocolitisUnited States
-
Children's Hospital Medical Center, CincinnatiMothers' Milk Bank NortheastTerminatedNorovirus InfectionsUnited States
-
Rennes University HospitalCompleted
-
Istanbul Medeniyet UniversityCompleted
-
Prolacta BioscienceCompletedInfant, Very Low Birth WeightUnited States, Austria
-
Laura KairThe Gerber Foundation; Children's Miracle NetworkCompletedExclusive Breastfeeding | Breastfeeding Duration | Donor Milk SupplementationUnited States
-
National and Kapodistrian University of AthensRecruiting
-
Tarah T ColaizyEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedNeurodevelopmental Outcomes of VLBW InfantsUnited States
-
Fundacion InfantCompletedRespiratory InfectionsArgentina
-
University of ManitobaUniversity of CalgaryRecruitingPreterm Birth | Microbial ColonizationCanada